EnsoData, BodiMetrics Collaborate to Expedite Sleep Testing, Expand Long-Term Monitoring

BodiMetrics, a leader in well-being and fitness monitoring devices, announces a partnership with EnsoData, a pioneer in healthcare AI, to power BodiMetrics’ FDA-cleared circul pro™ smart ring with the FDA-cleared EnsoSleep PPG software as a medical device (SaMD) to increase affordability and accessibility of home sleep apnea testing and longitudinal sleep monitoring.

The collaboration between BodiMetrics and EnsoData aims to expedite the patient care journey from initial home testing to longitudinal therapy monitoring. The accuracy, comfort, and flexibility of the circul pro™ ring, coupled with EnsoSleep PPG software, provides clinicians across the medical spectrum with an anytime, anywhere sleep diagnostic and ongoing monitoring solution.

With over a decade of development and more than five years of commercial history, BodiMetrics’ devices offer a proven track record of high-quality clinical use in sleep diagnostics, remote patient monitoring, veterans’ care, and clinical trials. The circul pro™ smart ring features sensor stabilization technology (SST), a spring-loaded and tapered design, to eliminate movement and slippage and ensure an optimal fit to collect the highest acuity data for patients of all skin tones, ensuring health equity across all populations.

As EnsoData’s third FDA clearance for an SaMD in sleep medicine, EnsoSleep PPG provides AI sleep scoring and analysis of the data collected by FDA-cleared pulse oximetry devices. The algorithm was validated by comparing the results of PPG-based testing against simultaneously recorded PSGs, demonstrating strong accuracy in detecting sleep-disordered breathing events, identifying sleep stages, and determining total sleep time. With this partnership, clinics will have the option of incorporating the circul pro™ ring for sleep testing with the accuracy and reliability of EnsoSleep PPG AI-powered diagnosis.

The partnership offers an affordable and scalable solution to test patients at home and across multiple nights. Research shows¹  that missed diagnoses of OSA in-home testing can be as high as 10% of patients across nights. That is why multi-night testing is so important, as highlighted by Dr. Meir Kryger, MD, FRCPC, Professor Emeritus of the Yale School of Medicine and Chief Scientific Advisor of BodiMetrics.

“Episodic and spot measurements of sleep data may miss the times when oxygen levels change quickly during sleep in some conditions. This leaves patients at risk of misdiagnosis,” said Dr. Kryger. “However, when devices can continuously measure oxygen saturation during sleep over multiple nights and AI can analyze that data, you can improve patient outcomes rather dramatically.”

“This partnership is another significant advancement in expanding patient access to quality sleep testing and patient monitoring,” stated Brock Hensen, COO of EnsoData. “We are excited to launch this collaboration with BodiMetrics and further expand the EnsoData ecosystem of partnerships with the circul pro™ ring. Simple, accessible options like this will ultimately be the way we address sleep apnea at scale.”

To learn more about the collaboration, visit www.ensodata.com/partners-bodimetrics.

Source: Ensodata

¹Roeder M, Bradicich M, Schwarz EI, et al. Night-to-night variability of respiratory events in obstructive sleep apnoea: a systematic review and meta-analysisThorax 2020;75:1095-1102.